QI Case Review — Protocol Deviation and Corrective Action

You are the EMS Medical Director reviewing a flagged QI case: a paramedic administered double-dose epinephrine during a cardiac arrest due to a LASA medication storage error. Navigate the investigation, root cause analysis, just culture corrective action, system redesign, reporting obligations, and 90-day follow-up audit.

The call

QI CASE REVIEW — Medical Director Perspective

You are the EMS Medical Director for a county EMS agency. Your QI coordinator has flagged a case for your review. A complaint was received from a receiving emergency physician regarding a prehospital care report (PCR) that documented a significant protocol deviation.

Case Summary:
- Incident: Cardiac arrest, residential, 2:47 AM
- Unit: Medic 7 (2-provider ALS unit)
- Crew: Alex Morgan (lead, 6 years experience) and Jordan Lee (partner, 2 years experience)
- Patient: 54-year-old male, found unresponsive by wife, unknown downtime

The receiving physician's concern: "The PCR documents epinephrine administered at 2 mg IV push (double the standard dose) for the first dose. The patient arrived in PEA with no ROSC. I need to know if this was intentional and what your agency's protocol says."

Your task: Review the PCR, identify the deviation, determine its clinical significance, and select the appropriate corrective action.

PCR Review

You review the PCR. Key documented findings:

Scene: Residential, 2:47 AM. Wife called 911 after finding husband unresponsive in bed. Last known well: 11 PM. The arrest time and duration without circulation are unknown.

Initial assessment: Unresponsive, apneic, pulseless. CPR initiated by wife (quality unknown). AED applied by fire first responders — no shock advised (asystole).

Rhythm: Asystole on arrival, converted to PEA (rate 40) after 8 minutes of CPR.

Airway: Supraglottic airway placed at 6 minutes. Waveform capnography confirmed.

Medications documented:
- 02:52 — Epinephrine 2 mg IV push (Alex Morgan)
- 02:57 — Epinephrine 1 mg IV push (Alex Morgan)
- 03:02 — Epinephrine 1 mg IV push (Alex Morgan)
- 03:05 — Amiodarone 300 mg IV push (Alex Morgan) ⚠️ *Note: Amiodarone is indicated for shock-refractory VF/pVT only — this patient was in asystole/PEA throughout. This represents a second potential protocol deviation.*

CPR quality: No ETCO2 values documented. No CPR feedback device documented.

Transport: Initiated at 03:08 (21 minutes on scene). Patient arrived in PEA, no ROSC.

Agency protocol for cardiac arrest: Epinephrine 1 mg IV/IO q3–5 minutes. Standard AHA ACLS algorithm.

Deviation identified: First epinephrine dose was 2 mg (double the protocol dose of 1 mg).

Decision 1 of 6: DECISION POINT — Clinical Significance of the Deviation

The first epinephrine dose was 2 mg instead of the protocol-specified 1 mg. How do you classify the clinical significance of this deviation?

  1. Not a deviation — medical directors can authorize dose modifications in real time
  2. Minor deviation — epinephrine dosing in cardiac arrest has minimal clinical impact given the poor prognosis
  3. Significant deviation — double dosing epinephrine in cardiac arrest has potential for harm and is outside evidence-based guidelines
  4. Significant deviation — this constitutes gross negligence requiring immediate license suspension

Choose your answer to see the feedback. The rest of the case, the scored debrief and the Virtual FTO review come with a subscription.

Written and reviewed by Chester Shermer, MD, FACEP, board-certified emergency physician and HEMS medical director.

See plans · Play a full scenario free · All scenarios